Blood cytokines as potential predictors of therapy effectiveness in patients with moderate to severe psoriasis treated with the IL-12/IL-23 inhibitor ustekinumab
Background. Despite the proven efficacy and safety of biologics in the treatment of psoriasis (Ps), a number of patients experience heterogeneity in response to therapy in both the short-term and long-term perspectives. Aims. To identify correlations between the blood cytokine levels, clinical se...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
State Scientific Center of Dermatovenereology and Cosmetology
2025-03-01
|
| Col·lecció: | Vestnik Dermatologii i Venerologii |
| Matèries: | |
| Accés en línia: | https://vestnikdv.ru/jour/article/viewFile/16814/pdf_1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|